Literature DB >> 32459663

COVID-19, microangiopathy, hemostatic activation, and complement.

Wen-Chao Song1,2, Garret A FitzGerald1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32459663      PMCID： PMC7410042          DOI： 10.1172/JCI140183

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  25 in total

1.  Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience.

Authors:  F Diurno; F G Numis; G Porta; F Cirillo; S Maddaluno; A Ragozzino; P De Negri; C Di Gennaro; A Pagano; E Allegorico; L Bressy; G Bosso; A Ferrara; C Serra; A Montisci; M D'Amico; S Schiano Lo Morello; G Di Costanzo; A G Tucci; P Marchetti; U Di Vincenzo; I Sorrentino; A Casciotta; M Fusco; C Buonerba; M Berretta; M Ceccarelli; G Nunnari; Y Diessa; S Cicala; G Facchini
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-04       Impact factor: 3.507

Review 2.  Paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

3.  A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways.

Authors:  Konstantinos Ritis; Michael Doumas; Dimitrios Mastellos; Anastasia Micheli; Stavros Giaglis; Paola Magotti; Stavros Rafail; Georgios Kartalis; Paschalis Sideras; John D Lambris
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

4.  Thrombocytopenia and its association with mortality in patients with COVID-19.

Authors:  Xiaobo Yang; Qingyu Yang; Yaxin Wang; Yongran Wu; Jiqian Xu; Yuan Yu; You Shang
Journal:  J Thromb Haemost       Date:  2020-05-04       Impact factor: 5.824

5.  Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation.

Authors:  Yoshiyasu Ueda; Takashi Miwa; Daisuke Ito; Hangsoo Kim; Sayaka Sato; Damodar Gullipalli; Lin Zhou; Madhu Golla; Delu Song; Joshua L Dunaief; Matthew B Palmer; Wen-Chao Song
Journal:  Kidney Int       Date:  2019-02-27       Impact factor: 10.612

Review 6.  Genetics and complement in atypical HUS.

Authors:  David Kavanagh; Tim Goodship
Journal:  Pediatr Nephrol       Date:  2010-06-06       Impact factor: 3.714

Review 7.  Natural IgM-mediated innate autoimmunity: a new target for early intervention of ischemia-reperfusion injury.

Authors:  Ming Zhang; Michael C Carroll
Journal:  Expert Opin Biol Ther       Date:  2007-10       Impact factor: 4.388

8.  The first case of COVID-19 treated with the complement C3 inhibitor AMY-101.

Authors:  Sara Mastaglio; Annalisa Ruggeri; Antonio M Risitano; Piera Angelillo; Despina Yancopoulou; Dimitrios C Mastellos; Markus Huber-Lang; Simona Piemontese; Andrea Assanelli; Cecilia Garlanda; John D Lambris; Fabio Ciceri
Journal:  Clin Immunol       Date:  2020-04-29       Impact factor: 3.969

9.  Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.

Authors:  Cynthia Magro; J Justin Mulvey; David Berlin; Gerard Nuovo; Steven Salvatore; Joanna Harp; Amelia Baxter-Stoltzfus; Jeffrey Laurence
Journal:  Transl Res       Date:  2020-04-15       Impact factor: 7.012

Review 10.  The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.

Authors:  Qing Ye; Bili Wang; Jianhua Mao
Journal:  J Infect       Date:  2020-04-10       Impact factor: 38.637
View more
  41 in total

1.  [Exploration of the therapeutic mechanism of Yiqi Jiedu recipe for treatment of primary liver cancer based on network pharmacology and molecular docking].

Authors:  M Xu; P Zhang; G Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-06-20

2.  Long-term neurologic outcomes of COVID-19.

Authors:  Evan Xu; Yan Xie; Ziyad Al-Aly
Journal:  Nat Med       Date:  2022-09-22       Impact factor: 87.241

Review 3.  Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Sadiq M Al-Hamash; Simona Cavalu; Maisra M El-Bouseary; Fatma I Sonbol; Gaber El-Saber Batiha
Journal:  Front Med (Lausanne)       Date:  2022-06-17

4.  SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care.

Authors:  Clemens Gutmann; Kaloyan Takov; Sean A Burnap; Bhawana Singh; Hashim Ali; Konstantinos Theofilatos; Ella Reed; Maria Hasman; Adam Nabeebaccus; Matthew Fish; Mark Jw McPhail; Kevin O'Gallagher; Lukas E Schmidt; Christian Cassel; Marieke Rienks; Xiaoke Yin; Georg Auzinger; Salvatore Napoli; Salma F Mujib; Francesca Trovato; Barnaby Sanderson; Blair Merrick; Umar Niazi; Mansoor Saqi; Konstantina Dimitrakopoulou; Rafael Fernández-Leiro; Silke Braun; Romy Kronstein-Wiedemann; Katie J Doores; Jonathan D Edgeworth; Ajay M Shah; Stefan R Bornstein; Torsten Tonn; Adrian C Hayday; Mauro Giacca; Manu Shankar-Hari; Manuel Mayr
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

5.  Thrombotic Microangiopathy in a Patient With COVID-19 Infection and Metastatic Cholangiocarcinoma.

Authors:  Shruti Sharma; Sushma Pavuluri; Krishnan Srinivasan; Masood Ghouse
Journal:  J Hematol       Date:  2021-04-27

6.  Severe acute respiratory Syndrome-Coronavirus-2: Can it be detected in the retina?

Authors:  Tarek Bayyoud; Angelika Iftner; Thomas Iftner; Karl Ulrich Bartz-Schmidt; Focke Ziemssen; Hans Bösmüller; Falko Fend; Jens Martin Rohrbach; Marius Ueffing; Michael Schindler; Sebastian Thaler
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

Review 7.  Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy.

Authors:  Filippo Milano; Joshua A Hill; Lorenzo Iovino; Laurel A Thur; Sacha Gnjatic; Aude Chapuis
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

8.  Medical Records-Based Genetic Studies of the Complement System.

Authors:  Atlas Khan; Ning Shang; Lynn Petukhova; Jun Zhang; Yufeng Shen; Scott J Hebbring; Halima Moncrieffe; Leah C Kottyan; Bahram Namjou-Khales; Rachel Knevel; Soumya Raychaudhuri; Elizabeth W Karlson; John B Harley; Ian B Stanaway; David Crosslin; Joshua C Denny; Mitchell S V Elkind; Ali G Gharavi; George Hripcsak; Chunhua Weng; Krzysztof Kiryluk
Journal:  J Am Soc Nephrol       Date:  2021-05-03       Impact factor: 14.978

9.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 10.  The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects.

Authors:  Nicola Semeraro; Mario Colucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-07-01       Impact factor: 2.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.